4-3074876-CCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAG-CCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAG

Variant summary

Our verdict is Benign. The variant received -11 ACMG points: 0P and 11B. BP3BP6_ModerateBS1BS2

The ENST00000355072.11(HTT):​c.93_110dupGCAGCAGCAGCAGCAGCA​(p.Gln32_Gln37dup) variant causes a disruptive inframe insertion change. It is difficult to determine the true allele frequency of this variant because it is of type INS_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.013 ( 33 hom., cov: 0)
Exomes 𝑓: 0.0045 ( 47 hom. )

Consequence

HTT
ENST00000355072.11 disruptive_inframe_insertion

Scores

Not classified

Clinical Significance

Benign criteria provided, single submitter U:1B:1

Conservation

PhyloP100: 4.84

Publications

6 publications found
Variant links:
Genes affected
HTT (HGNC:4851): (huntingtin) Huntingtin is a disease gene linked to Huntington's disease, a neurodegenerative disorder characterized by loss of striatal neurons. This is thought to be caused by an expanded, unstable trinucleotide repeat in the huntingtin gene, which translates as a polyglutamine repeat in the protein product. A fairly broad range of trinucleotide repeats (9-35) has been identified in normal controls, and repeat numbers in excess of 40 have been described as pathological. The huntingtin locus is large, spanning 180 kb and consisting of 67 exons. The huntingtin gene is widely expressed and is required for normal development. It is expressed as 2 alternatively polyadenylated forms displaying different relative abundance in various fetal and adult tissues. The larger transcript is approximately 13.7 kb and is expressed predominantly in adult and fetal brain whereas the smaller transcript of approximately 10.3 kb is more widely expressed. The genetic defect leading to Huntington's disease may not necessarily eliminate transcription, but may confer a new property on the mRNA or alter the function of the protein. One candidate is the huntingtin-associated protein-1, highly expressed in brain, which has increased affinity for huntingtin protein with expanded polyglutamine repeats. This gene contains an upstream open reading frame in the 5' UTR that inhibits expression of the huntingtin gene product through translational repression. [provided by RefSeq, Jul 2016]
HTT Gene-Disease associations (from GenCC):
  • Huntington disease
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae), Orphanet
  • Lopes-Maciel-Rodan syndrome
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • juvenile Huntington disease
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -11 ACMG points.

BP3
Nonframeshift variant in repetitive region in ENST00000355072.11
BP6
Variant 4-3074876-C-CCAGCAGCAGCAGCAGCAG is Benign according to our data. Variant chr4-3074876-C-CCAGCAGCAGCAGCAGCAG is described in ClinVar as Benign. ClinVar VariationId is 1049703.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.0132 (1745/131866) while in subpopulation AMR AF = 0.0199 (267/13410). AF 95% confidence interval is 0.0179. There are 33 homozygotes in GnomAd4. There are 882 alleles in the male GnomAd4 subpopulation. Median coverage is 0. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 33 AR,AD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000355072.11. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HTT
NM_001388492.1
MANE Select
c.93_110dupGCAGCAGCAGCAGCAGCAp.Gln32_Gln37dup
disruptive_inframe_insertion
Exon 1 of 67NP_001375421.1
HTT
NM_002111.8
c.93_110dupGCAGCAGCAGCAGCAGCAp.Gln32_Gln37dup
disruptive_inframe_insertion
Exon 1 of 67NP_002102.4

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HTT
ENST00000355072.11
TSL:1 MANE Select
c.93_110dupGCAGCAGCAGCAGCAGCAp.Gln32_Gln37dup
disruptive_inframe_insertion
Exon 1 of 67ENSP00000347184.5
HTT
ENST00000680291.1
n.238_255dupGCAGCAGCAGCAGCAGCA
non_coding_transcript_exon
Exon 1 of 41
HTT
ENST00000681528.1
c.6-12021_6-12004dupGCAGCAGCAGCAGCAGCA
intron
N/AENSP00000506116.1

Frequencies

GnomAD3 genomes
AF:
0.0133
AC:
1747
AN:
131768
Hom.:
33
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.0105
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0199
Gnomad ASJ
AF:
0.0279
Gnomad EAS
AF:
0.00459
Gnomad SAS
AF:
0.0115
Gnomad FIN
AF:
0.0129
Gnomad MID
AF:
0.0149
Gnomad NFE
AF:
0.0136
Gnomad OTH
AF:
0.0117
GnomAD4 exome
AF:
0.00450
AC:
5512
AN:
1225724
Hom.:
47
Cov.:
0
AF XY:
0.00482
AC XY:
2932
AN XY:
608080
show subpopulations
African (AFR)
AF:
0.00407
AC:
105
AN:
25810
American (AMR)
AF:
0.00888
AC:
269
AN:
30296
Ashkenazi Jewish (ASJ)
AF:
0.0169
AC:
385
AN:
22730
East Asian (EAS)
AF:
0.00199
AC:
58
AN:
29094
South Asian (SAS)
AF:
0.00541
AC:
391
AN:
72220
European-Finnish (FIN)
AF:
0.00920
AC:
299
AN:
32494
Middle Eastern (MID)
AF:
0.00397
AC:
15
AN:
3780
European-Non Finnish (NFE)
AF:
0.00380
AC:
3638
AN:
957468
Other (OTH)
AF:
0.00679
AC:
352
AN:
51832
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
190
380
571
761
951
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0132
AC:
1745
AN:
131866
Hom.:
33
Cov.:
0
AF XY:
0.0139
AC XY:
882
AN XY:
63416
show subpopulations
African (AFR)
AF:
0.0104
AC:
371
AN:
35514
American (AMR)
AF:
0.0199
AC:
267
AN:
13410
Ashkenazi Jewish (ASJ)
AF:
0.0279
AC:
89
AN:
3190
East Asian (EAS)
AF:
0.00436
AC:
18
AN:
4124
South Asian (SAS)
AF:
0.0113
AC:
44
AN:
3910
European-Finnish (FIN)
AF:
0.0129
AC:
95
AN:
7368
Middle Eastern (MID)
AF:
0.0159
AC:
4
AN:
252
European-Non Finnish (NFE)
AF:
0.0136
AC:
836
AN:
61484
Other (OTH)
AF:
0.0116
AC:
21
AN:
1814
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.546
Heterozygous variant carriers
0
62
124
186
248
310
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
452

ClinVar

ClinVar submissions as Germline

Significance:Benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
not provided (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
4.8
Mutation Taster
=80/20
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs71180116; hg19: chr4-3076603; API